The Second Affiliated Hospital Of Chongqing Medical University
Clinical trials sponsored by The Second Affiliated Hospital Of Chongqing Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New imaging technique aims to reduce lung damage during cancer radiation Results expected Dec 2026 (estimated)
- Could a new anesthetic keep your mind sharper after a procedure? Results expected Dec 2026 (estimated)
- Hepatitis b cure breakthrough? new combo aims for 50%+ cure rate Results expected Dec 2026 (estimated)
- New combo aims to cure hepatitis b in over half of patients Results expected Dec 2026 (estimated)
- New combo therapy aims to cure hepatitis b in over half of patients Results expected Dec 2026 (estimated)
-
Can a Weight-Loss drug ease pressure in cirrhosis?
Disease control Not yet recruitingThis trial tests whether mazdutide, a weekly injection that targets GLP-1 and glucagon receptors, can safely reduce portal pressure in overweight adults with compensated cirrhosis and clinically significant portal hypertension. Participants receive 16 weeks of mazdutide, with the…
Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Massive study to uncover how obesity and diabetes speed up liver damage
Knowledge-focused Not yet recruitingThis study follows over 4,300 adults with compensated advanced chronic liver disease to see how metabolic disorders like obesity, diabetes, and high cholesterol affect disease progression. Participants receive standard care and are monitored every 3 to 6 months for up to 5 years.…
Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New study aims to improve infection treatment in liver patients
Knowledge-focused Not yet recruitingThis study will look at how antimicrobial drugs are used in people with liver cirrhosis who develop severe infections (sepsis). Researchers will review medical records from 1600 patients to see which treatments work best. The goal is to find ways to reduce deaths within 28 days.
Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC